XML 59 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investment in Silver Creek - Additional Information (Detail) - USD ($)
$ in Thousands
12 Months Ended
Jul. 14, 2017
Dec. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Dec. 31, 2016
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]          
Gain on deconsolidation     $ 10,848    
Equity method investment   $ 7,428 10,551    
Loss on equity method investment   $ (3,123) (849)    
Maximum [Member] | Silver Creek Pharmaceuticals Inc [Member]          
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]          
Ownership interest percentage held by parent       50.00%  
Silver Creek Pharmaceuticals Inc [Member]          
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]          
Ownership interest percentage held   40.00%      
Gain on deconsolidation     10,848    
Investment at fair value $ 11,400   11,400    
Equity method investment   $ 7,400 10,600    
Loss on equity method investment   $ 3,100 $ 800    
Silver Creek Pharmaceuticals Inc [Member] | Minimum [Member]          
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]          
Ownership interest percentage held by parent and its de facto agents         50.00%
Ownership interest percentage held 20.00%        
Silver Creek Pharmaceuticals Inc [Member] | Maximum [Member]          
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Effects Of Changes Net [Line Items]          
Ownership interest percentage held 49.00%